Article info
Case Report
Acute visual loss after ipilimumab treatment for metastatic melanoma
- ↵a Melissa.Wilson{at}nyumc.org
- ↵b Kelly.Guld{at}ucsf.edu
- ↵c Steven.Galetta{at}nyumc.org
- ↵d rdwalsh{at}mcw.edu
- ↵e Julia.Kharlip{at}uphs.upenn.edu
- ↵f Madhura.Tamhankar{at}uphs.upenn.edu
- ↵g Suzanne.McGettigan{at}uphs.upenn.edu
- ↵h Lynn.Schuchter{at}uphs.upenn.edu
- ↵i 734-615-4762 LFecher{at}med.umich.edu
Citation
Acute visual loss after ipilimumab treatment for metastatic melanoma
Publication history
- Received March 24, 2016
- Accepted September 29, 2016
- First published October 18, 2016.
Online issue publication
October 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s). 2016
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.